Stylage S with Lido BiSoft 2×0.8ml is a hyaluronic acid–based dermal filler developed by Vivacy Laboratories, indicated primarily for the correction of fine to moderate facial wrinkles, superficial lines, and delicate volume support. Formulated with cross-linked hyaluronic acid and Stylage S lidocaine, this product incorporates an anaesthetic within the gel to improve patient comfort during injection. The BiSoft® syringe technology ensures controlled delivery, reduced extrusion force, and ergonomic handling, making it suitable for dynamic and sensitive areas such as the lips and under-eye region.

What Stylage S Is Similar To

Stylage S BiSoft can be clinically compared to other light to medium density hyaluronic acid fillers such as Juvederm Ultra 2, Restylane Refyne, and Teosyal RHA 2, which offer smooth tissue integration, hydration, and soft correction of fine lines. Unlike high-projection fillers designed for deep volume, Stylage S filler is optimised for surface contouring, hydration, and subtle enhancement, particularly where natural movement is essential. This comparison is offered for professional orientation only and does not imply interchangeability of products.

Treatment Areas / Indications

According to manufacturer documentation and clinical practice, Stylage S with Lido is indicated for:
Treatment areas:

• Fine perioral and nasolabial lines

• Superficial facial wrinkles

• Lip enhancement (Stylage S for lips)

• Under-eye contouring and hydration (Stylage S under eye)

• Tear-trough texture support
  → Stylage S is frequently selected for patients seeking subtle enhancement and skin quality improvement in delicate regions with minimal bulk.

Usage / Administration (IFU-only)

Injection depth: Superficial to mid-dermis depending on anatomical site and indication.
Volume per injection site: Administered in small aliquots; total volume tailored per patient assessment.
Needle gauge: Fine gauge needles provided for controlled, precise placement.
Frequency / number of sessions: Typically one session may suffice; additional touch-ups can be performed based on clinical response.
Professional-use disclaimer: Administered by qualified medical or aesthetic professionals only under aseptic conditions.
If any parameter is omitted in the official IFU, it is marked not provided by manufacturer.

Ingredient List

• Hyaluronic acid sodium salt: Cross-linked HA optimised for smooth tissue integration and hydration.

• Lidocaine hydrochloride: Local anaesthetic incorporated to improve injection comfort.

• Additional excipients include physiologic buffers as specified in the IFU; trace components not disclosed.